| Accession Number | 0001857721-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 24, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sr. VP Mktg & Clinical Affairs | Common Stock | โ | Feb 20, 2026 | Grant/Award | 3,490 | $0.00 | $0.00 | 82,085 | Direct | โ | View Details | |
Sr. VP Mktg & Clinical Affairs | Common Stock | โ | Feb 20, 2026 | Grant/Award | 4,058 | $0.00 | $0.00 | 86,143 | Direct | โ | View Details | |
Sr. VP Mktg & Clinical Affairs | Common Stock | โ | Feb 20, 2026 | Grant/Award | 7,123 | $0.00 | $0.00 | 93,266 | Direct | โ | View Details | |
Sr. VP Mktg & Clinical Affairs | Common Stock | โ | Feb 23, 2026 | Sale | 4,279 | $28.28 | $121,021.67 | 88,987 | Direct | โ | View Details | |
Sr. VP Mktg & Clinical Affairs | Common Stock | โ | Feb 23, 2026 | Sale | 160 | $28.69 | $4,590.29 | 88,827 | Direct | โ | View Details |